---
schema_version: "secwatch.filing_event.v1"
accession: "0001161697-26-000055"
form_type: "8-K"
ticker: "KRMD"
cik: "0000704440"
company_name: "KORU Medical Systems, Inc."
filed_at: "2026-03-16T23:59:59+00:00"
generated_at: "2026-05-15T12:09:59.742669+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CEO Linda Tharby to retire June 2026; Adam Kalbermatten named successor

## Summary
- Tharby retires as CEO effective June 30, 2026; will serve as advisory employee through Dec 31, 2026.
- Kalbermatten appointed President March 15, 2026, and becomes CEO July 1, 2026.
- Kalbermatten's base salary: $450K through June, then $525K; 2026 bonus target 80%; LTI target $1.25M.
- One-time PSU award of $1.25M to Kalbermatten effective July 1, 2026 with performance goals (75% revenue growth, 25% market cap).
- Tharby's equity: some PSUs/RSUs continue vesting through Dec 31, 2026; all remaining unvested awards forfeited thereafter.

## SEC filing metadata
- accession: 0001161697-26-000055
- form_type: 8-K
- ticker: KRMD
- cik: 0000704440
- company_name: KORU Medical Systems, Inc.
- filed_at: 2026-03-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/704440/000116169726000055/0001161697-26-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/704440/000116169726000055/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001161697-26-000055
- JSON: https://secwatch.observer/filing/0001161697-26-000055.json
- Plain text: https://secwatch.observer/filing/0001161697-26-000055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.